| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.814 | 44.527 | 43.999 | 36.126 | 53.962 | 82.195 | 99.713 | 110.488 | 230.293 | 234.818 |
| Total Income - EUR | 42.815 | 44.973 | 44.000 | 36.126 | 53.963 | 82.196 | 99.714 | 113.346 | 230.294 | 234.933 |
| Total Expenses - EUR | 22.778 | 25.819 | 27.166 | 29.174 | 64.123 | 93.255 | 101.663 | 125.518 | 226.574 | 323.528 |
| Gross Profit/Loss - EUR | 20.037 | 19.154 | 16.834 | 6.952 | -10.160 | -11.059 | -1.949 | -12.173 | 3.720 | -88.595 |
| Net Profit/Loss - EUR | 18.756 | 18.255 | 16.394 | 6.594 | -10.700 | -11.847 | -2.689 | -13.105 | 1.424 | -95.643 |
| Employees | 2 | 2 | 2 | 2 | 4 | 4 | 5 | 4 | 5 | 8 |
Check the financial reports for the company - Medicare Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.484 | 19.760 | 13.446 | 7.535 | 10.089 | 5.265 | 2.955 | 1.529 | 173.404 | 144.343 |
| Current Assets | 32.734 | 15.207 | 9.067 | 6.556 | 19.983 | 14.986 | 10.979 | 26.636 | 43.124 | 37.139 |
| Inventories | 0 | 0 | 0 | 0 | 11.627 | 1.568 | 0 | 2.774 | 7.940 | 6.397 |
| Receivables | 217 | 660 | 3.253 | 3.036 | 5.746 | 7.479 | 8.688 | 17.550 | 17.517 | 10.286 |
| Cash | 32.517 | 14.547 | 5.814 | 3.520 | 2.609 | 5.939 | 2.291 | 6.312 | 17.668 | 20.456 |
| Shareholders Funds | 32.570 | 25.998 | 19.178 | 11.848 | -5.949 | -17.682 | -19.979 | -33.146 | -31.620 | -127.087 |
| Social Capital | 45 | 45 | 44 | 43 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 1.647 | 8.969 | 3.335 | 2.244 | 36.021 | 37.934 | 33.913 | 61.311 | 248.148 | 308.570 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medicare Laboratory S.r.l.